Ameride

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ameride

Property Description
Active Ingredients Amiloride hydrochloride, Hydrochlorothiazide
Form Tablet (oral administration)
Pharmacological Class Potassium-sparing Diuretics with Thiazides
General Purpose Fluid regulation, Antihypertensive activity
Origin Synthetic

Defining Ameride: A Combination Diuretic and Its Composition

Ameride is a synthetic, prescription-only, fixed-dose combination product administered via the oral route as a tablet. It is primarily classified as a Combination Diuretic, falling under the broader class of Potassium-sparing Diuretics with Thiazides. The medication is defined by its co-formulation of two distinct active ingredients: Amiloride hydrochloride and Hydrochlorothiazide (HCTZ). This fixed combination ensures the simultaneous delivery of both compounds, distinguishing it from single-agent diuretics. This combination therapy is used as a strategy for managing fluid balance. This means the product contains a specific blend of medicines designed to work together to improve fluid control. Formulations containing Amiloride and Hydrochlorothiazide are commonly known under various brand names, such as Moduretic, highlighting the clinical focus on synergistic diuretic action.

General Purpose: Fluid Regulation and Potassium Balance

The general purpose of Ameride is to support the regulation of body fluid volume and contribute to antihypertensive activity. Its dual composition supports this function by inducing natriuresis and diuresis—the increased excretion of sodium, chloride, and water. This combination is intended to be beneficial because the Amiloride component acts to conserve potassium, a measure to counteract the kaliuretic effect (potassium loss) that is characteristic of the Hydrochlorothiazide component. Amiloride is added to help protect your body's potassium levels while the diuretic is working. By managing fluid volume while maintaining electrolyte balance, Ameride is typically used in managing conditions characterized by fluid excess and elevated pressure within the cardiovascular system, offering a solution designed to minimize the risk of diuretic-induced potassium depletion.

What side effects are possible with Ameride?

Possible Side Effects and Safety Information

The officially documented safety profile for Ameride (Amiloride and Hydrochlorothiazide) is structured around potential electrolyte imbalance and systemic effects, as recognized in regulatory labeling. The most significant safety concern is the risk of Hyperkalemia (high potassium levels), which is classified as a serious adverse reaction, particularly in the presence of renal impairment or diabetes mellitus.

Adverse reactions are classified by frequency, with Common (Incidence ge 1%) effects spanning several systems:

System-Organ Class Common Adverse Reactions Documented
Body as a Whole Headache, Weakness, Fatigue/Tiredness
Gastrointestinal Nausea/Anorexia, Diarrhea, Abdominal pain
Metabolic Hyperkalemia, Hyperglycemia, Elevated BUN

The official label highlights specific serious adverse reactions associated with the Hydrochlorothiazide component, including Acute Transient Myopia and Secondary Angle-Closure Glaucoma, which can potentially lead to permanent vision loss, and an increased risk of Non-Melanoma Skin Cancer (NMSC) with long-term cumulative use. Effects such as dizziness and Orthostatic Hypotension are documented as being more common during the initiation of treatment.

Safety restrictions prohibit the use of Ameride in conditions such as existing Hyperkalemia (serum potassium ge 5.5 mEq/L), Anuria, Acute/Chronic Renal Insufficiency, and concomitant use with other Potassium-Conserving Agents.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Ameride (Amiloride/Hydrochlorothiazide) is defined by the exaggerated pharmacological effects documented in regulatory prescribing information, resulting in two primary, serious physiological consequences. These are profound volume depletion (severe dehydration) and dangerous electrolyte imbalances.

Overdose manifestations may include symptoms such as extreme drowsiness, confusion, muscular weakness, cramps, and gastrointestinal distress (nausea or vomiting). More critical manifestations include severe hypotension (low blood pressure) and life-threatening cardiac arrhythmias due to uncorrected hyperkalemia (high potassium), which can progress to cardiac arrest.

When to Seek Urgent Medical Help

Regulatory documents state that an individual must seek immediate medical attention upon suspicion of overdose. Emergency services must be contacted immediately if the patient is experiencing seizures, collapses, or has difficulty breathing. Due to the high risk of fatal arrhythmia from hyperkalemia, patients with impaired renal function or Diabetes Mellitus are noted to be at increased risk of severe outcomes.

Management and Monitoring

No specific antidote is known for this combination product. Management described in official sources is symptomatic and supportive treatment, including immediate drug discontinuation and monitoring of serum electrolytes and the ECG (electrocardiogram). Specific interventions, such as the use of insulin/glucose or cation exchange resins, are required to manage severe hyperkalemia.

Therapeutic Uses of Ameride

What Ameride Treats: Main Uses and Benefits

This medication is relevant for managing conditions characterized by periods of heightened symptoms related to systemic imbalance and high systemic pressure. Ameride is commonly used to help manage essential hypertension and to address the fluid accumulation of edema linked to conditions like Chronic Heart Failure or liver disorders. It assists with the reduction of symptom clusters that interfere with daily functioning, such as pronounced swelling and elevated vascular pressure.

A specialized benefit plays a role in addressing symptoms related to systemic imbalance where the potential for low potassium levels (hypokalemia) is a high risk. This combination supports the patient during difficult episodes by easing distress and helping to maintain functional stability.

“Ameride is commonly used when short-term symptomatic assistance is needed to help manage blood pressure and assist with persistent fluid retention.”

The primary therapeutic benefit is long-term support that generally assists in reducing the risk associated with severe complications and helps patients cope more steadily with symptoms related to physical discomfort.


Quick Fact: Relief for Fluid Overload and Electrolyte Imbalance Ameride is commonly used when symptoms of fluid retention or swelling create noticeable physiological strain, combined with an indication for supportive potassium management.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ameride? — Official Regulatory Information

Eligibility Scope

Ameride is intended for use in Adults with established conditions, such as Essential Hypertension or Edema related to cardiac or liver disorders.

Populations for whom use is Contraindicated

Use is strictly prohibited in patients with Anuria (inability to produce urine), Severe Renal Impairment, or Diabetic Nephropathy. It must not be used in the presence of Hyperkalemia (elevated serum potassium > 5.5 mEq/L) or when taking other Potassium-Sparing Diuretics or Potassium Supplements. A history of Hypersensitivity to the drug or any sulfonamide-derived medicine is also an absolute contraindication.

Age and Life-Stage Restrictions

The medicine is not recommended for children or adolescents because its safety and effectiveness in the pediatric population are not established. Use is also not recommended for women who are pregnant or breastfeeding.

Condition-Specific Eligibility Restrictions

Use is restricted and may be contraindicated in patients with severe hepatic failure due to the risk of hepatic coma. Caution is generally advised for older adults.

What should I know about interactions with other medicines?

Official Documented Interactions

Ameride, a combination diuretic of Amiloride and Hydrochlorothiazide, has officially documented interaction patterns focused primarily on electrolyte balance and blood pressure effects, as stated in regulatory labeling.

Formal Contraindications and Restrictions

Co-administration is contraindicated with certain substances due to the risk of severe complications. This includes Potassium Supplements and other Potassium-Sparing Agents (such as Spironolactone, Triamterene, and Eplerenone) because of the documented risk of severe hyperkalemia (elevated serum potassium). The concomitant use of the antiarrhythmic agent Dofetilide is also restricted based on official prescribing information.

Clinically Significant Pharmacodynamic Interactions

  • Lithium: The diuretic component reduces the renal clearance of Lithium, significantly increasing the risk of toxicity.
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Co-administration may result in the reduction of the diuretic and antihypertensive effects, increasing the risk of acute renal failure in certain conditions.
  • Other Antihypertensives, Alcohol, or Narcotics: These substances may lead to an additive hypotensive effect, potentiating the risk of orthostatic hypotension.
  • Digitalis Glycosides: The potential for diuretic-induced hypokalemia may increase the risk of Digoxin toxicity.

Exposure and Administration Timing Rules

Resin products, such as Cholestyramine and Colestipol, impair the absorption of the Hydrochlorothiazide component. To maintain adequate drug exposure, regulatory constraints require Ameride to be administered at least 4 hours before or 4–6 hours after these resins.

Interactions involving the Amiloride component may be accentuated in patients with impaired renal function, increasing the risk of hyperkalemia in this population.

Mechanism of Action

How Ameride Works

Ameride is a molecular modulator designed to precisely regulate signaling processes. Its mechanism of action operates across distinct domains, primarily by influencing key receptor-mediated pathways and subsequent intracellular cascades, which collectively influences the activity state within the affected pathways.

Targeted Receptor and Enzyme Modulation

Ameride acts within domains involving receptor- or enzyme-mediated signaling that govern downstream cellular responses. It initiates or suppresses specific early molecular steps to modulate the signaling magnitude resulting from excessive mediator activity.

Regulation of Intracellular Signaling Cascades

Ameride engages mechanisms that influence the feedback regulation within key signaling cascades. By modifying the early molecular steps, Ameride influences the kinetics of processes driven by distinct signaling patterns.

Influence on Physiological Output

Ameride alters activity within pathways that control localized physiological function, resulting in downstream changes to localized physiological output. This action alters the signaling equilibrium within the targeted biological systems.

Dosage and Administration Information

Official Administration Guidelines

Ameride is a fixed-dose combination product containing Amiloride and Hydrochlorothiazide (HCTZ) that is administered exclusively via the oral route as a tablet. The formulation combines Amiloride (5 mg) and Hydrochlorothiazide (50 mg) in a fixed ratio, which defines the standard unit of use.

Dosing and Frequency

Dosage Component Standard Instruction
Starting Dose One tablet daily (5 mg Amiloride / 50 mg HCTZ).
Maximum Daily Dose Two tablets (10 mg Amiloride / 100 mg HCTZ total).
Frequency Pattern Typically administered once daily. The two-tablet maximum dose may be given in divided doses.

Contextual and Procedural Instructions

To maintain the intended delivery profile, the tablets must be swallowed whole. The medicine is taken with food or immediately following a meal. Furthermore, this combination product is generally not indicated for the initial therapy of fluid retention or high systemic pressure. Maintenance protocols, particularly for fluid management, may involve a transition to an intermittent dosing basis following the achievement of initial fluid loss.

Population-Specific Use Rules

Specific restrictions apply related to patient status. The product is not recommended for use in individuals with significant kidney impairment (e.g., Creatinine Clearance leq 30 mL/min). For older adults, dosage adjustment must be undertaken carefully, with specific consideration given to renal function. Use in pediatric patients has not been established.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ameride

This overview summarizes the official research that has examined Ameride (Amiloride/Hydrochlorothiazide) as reported in scientific and regulatory documents. It describes the types of studies conducted and what the findings generally suggest, without offering any medical advice or interpretation.


Evidence for Use in Essential Hypertension (High Blood Pressure)

Research has examined Ameride's role in essential hypertension through Randomized Controlled Trials (RCTs) and long-term observational studies. Researchers primarily monitored changes in Systolic and Diastolic Blood Pressure readings. Research examined the combination's impact on serum potassium levels when compared against Hydrochlorothiazide (HCTZ) used alone. Some trials described patterns where the combination therapy measurements of potassium differed from those observed when HCTZ was used as a single agent.

Longer observational settings evaluated the occurrence of major Cardiovascular Events (CVEs), such as stroke and coronary issues, in observed cohorts using this drug class over several years. The results apply only to the populations studied, and the data may stem from trials where the fixed combination was a representative diuretic treatment arm.


Evidence for Use in Edema (Fluid Accumulation)

The combination was evaluated in clinical studies focused on examining fluid volume changes in cases linked to Congestive Heart Failure or fluid accumulation associated with Hepatic Cirrhosis. The combination is studied for its use in fluid management, which includes an evaluation of the role of the Amiloride component on potassium monitoring. Studies reported measurements where fluid excretion changed in observed populations and described patterns in serum potassium and sodium shifts.

However, the research for edema often focuses on short-term surrogate markers—such as weight or urine output—rather than on long-term clinical outcomes like reducing hospitalization rates. This means the evidence base is primarily concentrated on temporary physiological shifts.


What Is Still Uncertain About Ameride's Research Base

The research surrounding Ameride includes several limitations. The evidence quality varies across studies, and many comparative trials included older monotherapies rather than making direct comparisons against modern, newer treatments. Follow-up durations were limited in many initial efficacy trials, meaning long-term data on outcomes like reducing hospitalization is not fully established. Finally, while the research provides context, it does not determine whether an individual will respond similarly, as findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Hydrochlorothiazide: Drug Information (MedlinePlus Drug Information)
  2. Clinical Guideline: Hypertension in adults: diagnosis and management (NICE)

Frequently Asked Questions (FAQ)

Common questions about Ameride (FAQ)


Q: How quickly should someone start feeling the effects of Ameride?

According to official product information, the diuretic effect of the Amiloride component, one of the drug's active ingredients, typically begins relatively quickly. This effect is described as starting within about two hours following oral administration.


Q: What is the expected duration of action for Ameride?

The diuretic effects of Ameride are considered long-lasting enough to support a once-daily schedule. Official sources state that the effects of the Amiloride component generally persist for about 24 hours after a dose.


Q: Is Ameride considered a relatively new or old drug?

The fixed-dose combination of Ameride (Amiloride/Hydrochlorothiazide) is not considered a new medication. The product is known under various established brand names and has a history of clinical use in managing fluid balance and blood pressure.


Q: Is Ameride known to cause weight gain or loss?

Official documents on the product's side effect profile indicate that effects on appetite and weight may occur. The profile includes reports of weight loss (anorexia), and in rare instances, weight gain has been reported with the Hydrochlorothiazide component.


Q: Is there a generic version of Ameride available?

Yes, the Amiloride/Hydrochlorothiazide fixed-dose combination product is available in a generic form. This means that versions containing the same active ingredients are often manufactured and available.


Q: If I miss taking Ameride, what should I generally do?

Official instructions typically state that if a dose is missed, it should be taken as soon as it is remembered. If it is almost time for the next scheduled dose, instructions usually advise skipping the missed dose and continuing with the regular schedule. Regulatory warnings typically specify that a double dose should not be taken to make up for a missed dose.


Q: What should be done if an interaction with Ameride is suspected?

Regulatory guidance emphasizes the importance of consulting a healthcare professional if a drug interaction is suspected or if new symptoms occur. This involves checking with a prescribing doctor or pharmacist before starting, stopping, or changing the dosage of any medicine.


Q: Are there specific tests required before starting Ameride?

Yes, regulatory documents recommend specific monitoring before starting this medication. Official monitoring recommendations include assessing serum potassium and kidney function (such as serum creatinine) to establish baseline levels.


Q: Can Ameride cause skin sensitivity to the sun?

Official warnings note that Ameride can make a person more sensitive to the sun and UV light. This effect is associated with the Hydrochlorothiazide component. Regulatory documents recommend the use of protective clothing and sunscreen for individuals taking the medication due to this known sensitivity.


Q: What is the meaning of the warning about driving or operating machinery while using Ameride?

This warning is included because the drug can cause side effects such as dizziness, lightheadedness, or fainting. These effects may temporarily impair cognitive function or reaction time, particularly when starting treatment or following a dosage change.


Q: Does taking Ameride require any lifestyle changes?

Official guidance may include recommendations such as limiting sun exposure, monitoring fluid intake (due to the diuretic action), and noting that alcohol use may lead to additive blood pressure lowering effects.


Q: What kind of monitoring is typically recommended while taking Ameride?

Regulatory guidance specifies that regular monitoring of serum potassium, sodium, and kidney function (creatinine and BUN) is necessary. This is particularly important when therapy is initiated or the dosage is adjusted.


Q: Are there any specific safety alerts or warnings for Ameride that have been issued recently?

The FDA has issued a boxed warning for the fixed-dose combination product. This warning specifically highlights the potential risk for high potassium levels (hyperkalemia), which can lead to serious heart rhythm problems.


Q: Is Ameride for long-term or short-term treatment?

Official administration guidelines state that Ameride is generally not indicated for initial therapy for high blood pressure or fluid retention. Instead, it is intended for maintenance protocols, often transitioning to an intermittent dosing basis for long-term fluid management.


Q: Why is Ameride prescribed instead of a different medicine for the same condition?

Ameride is a two-component drug designed to address a common issue with diuretics. The combination is used because the Amiloride helps conserve potassium, counteracting the potassium-losing (kaliuretic) effect of the Hydrochlorothiazide component.


Q: Can vitamins or supplements be taken at the same time as Ameride?

Official prescribing information states that Potassium Supplements and other potassium-conserving agents are contraindicated (strictly prohibited) due to the high risk of severe hyperkalemia. Information on other vitamin and mineral supplements should be reviewed by a prescribing professional to check for potential interactions.


Q: Are there specific foods or drinks to avoid while using Ameride?

Official warnings note that individuals should avoid salt substitutes and low-sodium milk products that contain potassium. Guidance also recommends limiting a high intake of potassium-rich foods (such as melons, bananas, and orange juice) due to the potassium-sparing component of the medicine.


Q: Is Ameride safe for use in older adults?

The risk of hyperkalemia (high potassium) is noted to be increased in older adults. For this population, official documents emphasize the need for careful dosage consideration and close monitoring of renal function.


Q: What does the research say about Ameride for women's health issues?

Official regulatory information focuses on life-stage risks, specifying that use is not recommended during pregnancy or breastfeeding. This is because the effects on the nursing infant are unknown, and there is a potential for serious adverse reactions.


Q: What does 'contraindication' mean in relation to Ameride?

A contraindication is a circumstance that makes the use of a drug strictly prohibited. For Ameride, this means a patient has a specific medical condition (like dangerously high potassium or severe kidney disease) or is taking a substance that makes the use of the drug strictly prohibited due to the high risk of harm.


Q: How does Ameride affect the liver, according to official documents?

Regulatory documents state that use requires caution in patients with hepatic impairment (liver disease). This caution is advised because minor fluid and electrolyte changes caused by the diuretic may potentially trigger hepatic coma in the setting of severe liver issues.


Q: Is it important to take Ameride at the exact same time every day?

Instructions advise taking the medication around the same time every day to help a person adhere to the treatment schedule. It is typically administered once daily in the morning, which aligns with its 24-hour duration of action.


Q: What is the longest period of time people have studied Ameride use?

The drug belongs to a class of medications that have been studied extensively over time. Official research has evaluated the drug class in long-term observational settings over several years, allowing for monitoring of major Cardiovascular Events.


Q: Are there any known long-term effects of using Ameride?

Yes, regulatory documents indicate that long-term cumulative use of the Hydrochlorothiazide component is associated with an increased risk of Non-Melanoma Skin Cancer (NMSC). This finding is documented in the long-term safety information for the medication.


Q: Is the effectiveness of Ameride consistent across different age groups?

Regulatory information indicates that the efficacy in the pediatric population is not established. For older adults, the official labeling notes that dosage adjustment is often required due to consideration of renal function, which can influence effectiveness.


Q: How do the benefits of Ameride outweigh the risks, according to research?

Research describes the product's benefits in controlling fluid volume and blood pressure while minimizing potassium loss. This is balanced against documented risks, including the severe hyperkalemia (high potassium) highlighted by the boxed warning, and the risk of Non-Melanoma Skin Cancer from long-term use.

How should Ameride be stored and disposed of?

Storage and Disposal Instructions for Ameride

Ameride must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F to 77 F), with temporary excursions permitted outside this range. It is mandatory to keep the tablets from freezing and to store them away from excess heat, moisture, and direct light. The product should remain in the container it was dispensed in, and the cap must be kept tightly closed to maintain its integrity.

Safety and Disposal

Ameride must be secured out of the sight and reach of children at all times; federal guidance recommends locking safety caps. For disposal, unused or expired product must be discarded according to local regulations and should not be thrown into household waste or flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ameride found in:

A-Z Index: